As of 2025-09-18, the Relative Valuation of Turning Point Therapeutics Inc (TPTX) is (102.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.01 USD, the upside of Turning Point Therapeutics Inc based on Relative Valuation is -235.1%.
The range of the Relative Valuation is (98.56) - (106.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 15.5x | 14.9x |
| Forward P/E multiples | 14.2x - 15.6x | 14.9x |
| Fair Price | (98.56) - (106.83) | (102.69) |
| Upside | -229.7% - -240.5% | -235.1% |
| Date | P/E |